Company / SG&A per Share
Integra Lifesciences Holdings SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$8.71
FY2025
5-year range
$7.23 / $8.71
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#51 of 156
Health Care
What the data says
At $8.71, Integra Lifesciences Holdings's sg&a per share ranks #106 of 156 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $7.23 in FY2022 to $8.71 in FY2025.
Based on SEC 10-K filings.
8.71 in FY2025 with a 5-year CAGR of +4.2%.
Increased from $7.68 to $8.71 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#106 of 156 in Health CareTop 67% of 156This company $8.71 Sector average $11421.53
▼
-99.9% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 1.5% year-over-year.
- Ranks #51 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.71 | +1.5% |
| FY2024 | $8.58 | +11.8% |
| FY2023 | $7.68 | +6.2% |
| FY2022 | $7.23 | -1.9% |
| FY2021 | $7.37 | +4.1% |
| FY2020 | $7.08 | -18.6% |
| FY2019 | $8.69 | -0.4% |
| FY2018 | $8.72 | +49.7% |
| FY2017 | $5.83 | +2.3% |
| FY2016 | $5.70 | -60.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026